MUDr. Tomáš Doležal, Ph.D.
Research specialist, Department of Pharmacology
correspondence Address:
Kamenice 753/5, 625 00 Brno
e‑mail: |
---|
Total number of publications: 17
2023
-
Novel approach to decision making for orphan drugs
International Journal of Technology Assessment in Health Care, year: 2023, volume: 39, edition: 1, DOI
-
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study
Expert Review of Gastroenterology & Hepatology, year: 2023, volume: 17, edition: 1, DOI
-
Short-term risk of periprocedural stroke relative to radial vs. femoral access: systematic review, meta-analysis, study sequential analysis and meta-regression of 2,188,047 real-world cardiac catheterizations
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, year: 2023, volume: 21, edition: 4, DOI
-
The Impact of Subclinical Hypothyroidism on the Quality of Life During Pregnancy: Mapping 5-Level Version of EQ-5D and ThyPRO-39
Value in health, year: 2023, volume: 26, edition: 7, DOI
2022
-
Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic
IMMUNOTHERAPY, year: 2022, volume: 14, edition: 14, DOI
-
Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, year: 2022, volume: 22, edition: 8, DOI
-
Relationship between Patient Preferences, Attitudes to Treatment, Adherence, and Quality of Life in New Users of Teriflunomide
Pharmaceuticals, year: 2022, volume: 15, edition: 10, DOI
-
Time in remission as an alternative outcome measure for rheumatoid arthritis: a 10-year prospective study of 2618 new users of anti-TNF
RHEUMATOLOGY, year: 2022, volume: 61, edition: 6, DOI
2021
-
Accession Site Does Not Influence the Risk of Stroke after Diagnostic Coronary Angiography or Intervention: Results from a Large Prospective Registry
CEREBROVASCULAR DISEASES EXTRA, year: 2021, volume: 11, edition: 3, DOI
-
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn's Disease
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, year: 2021, volume: 19, edition: 4, DOI